{"name":"EVIVE Biotechnology","slug":"evive-biotechnology","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"GRAN®","genericName":"GRAN®","slug":"gran","indication":"Chemotherapy-induced nausea and vomiting","status":"marketed"},{"name":"RYZNEUTA","genericName":"EFBEMALENOGRASTIM ALFA-VUXW","slug":"efbemalenograstim-alfa-vuxw","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"F-627","genericName":"F-627","slug":"f-627","indication":"Chemotherapy-induced neutropenia (CIN) in patients with cancer receiving myelosuppressive chemotherapy","status":"phase_3"}]}],"pipeline":[{"name":"GRAN®","genericName":"GRAN®","slug":"gran","phase":"marketed","mechanism":"5-hydroxytryptamine receptor 3B, Multidrug and toxin extrusion protein 1, Solute carrier family 22 member 2","indications":["Chemotherapy-induced nausea and vomiting","Post-Operative Nausea and Vomiting","Prevention of Post-Operative Nausea and Vomiting","Prevention of Radiation-Induced Nausea and Vomiting"],"catalyst":""},{"name":"F-627","genericName":"F-627","slug":"f-627","phase":"phase_3","mechanism":"F-627 is a long-acting granulocyte colony-stimulating factor (G-CSF) analog that stimulates neutrophil production and mobilization.","indications":["Chemotherapy-induced neutropenia (CIN) in patients with cancer receiving myelosuppressive chemotherapy"],"catalyst":""},{"name":"RYZNEUTA","genericName":"EFBEMALENOGRASTIM ALFA-VUXW","slug":"efbemalenograstim-alfa-vuxw","phase":"marketed","mechanism":"Efbemalenograstim alfa-vuxw binds to specific cell surface receptors on hematopoietic cells, stimulating their proliferation, differentiation, and functional activation.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQZDJ6Zk54ckFkZElrSEVJc0hESVQyUDlValc2VjJiWnlwM2JyOTMtMk1mQ1BrNlBZTWVzaHNlQ2JyX2tuUnhCYXhwd2Q1WFVXdkxFQW9kZmNmbGpOSDZKczJDNzRDNFoxdkhSU1N6MEdEWjRsZWFDR1Y0Y2JxeXhiYTIyYzVRZ0xs?oc=5","date":"2025-04-24","type":"pipeline","source":"Mercator Institute for China Studies (MERICS)","summary":"Lab leader, market ascender: China's rise in biotechnology - Mercator Institute for China Studies (MERICS)","headline":"Lab leader, market ascender: China's rise in biotechnology - Mercator Institute for China Studies (MERICS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTFBaVVp2N0cwRF9tWGRvY2NfR25HTWJ0SV9hZHNfU0haUDNnTWpoV0VmWHJGUmh0RWoyUWxBWmowdnRCZ3JCMW1DN2dMbFltLVZNNUlKRUNmb1RadnNQbHNqNzRLUnlpc2h4ZUgw?oc=5","date":"2024-06-27","type":"pipeline","source":"The Pharma Letter","summary":"Evive Biotech - The Pharma Letter","headline":"Evive Biotech","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-11-29","type":"regulatory","source":"Medical Dialogues","summary":"Aurobindo Pharma bags USFDA nod for HIV drug Darunavir - Medical Dialogues","headline":"Aurobindo Pharma bags USFDA nod for HIV drug Darunavir","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPanRYT0FITzh6dWY0dldKXzhIRUo2WEhjVWZUbmFyWDBGYXljdlhxOF9wekFZY1o4ZGxhei1yX1FmVG54Qk1jaV9BaTkwc2EwT2JoRFZpQUVVLUtPYUZTd2dpRVlhX1RncGc3NlpDNFptaDZURmVXbnlrZzFxSGFubVJhM25mTldTQ1ZQYlk4UGVPbG5tN2NHZkxnbDI2RUoydE5TSDktTHFLdDlkcmZVbVhCbjY2ODhSUi1wRVR5WGZFdWdlUWE4YjkyUGjSAdIBQVVfeXFMT0c1Zng0NUt6aEUtR1J0WUtUX0lxVnVKRGVnOXZoNDE2aEliWW1TRFdvRXUzMEF5blIzREhtRUxqUGxjZmJ4NzNrbUlQQ25DdU80bkg5NEdDeThDS3ZGWm9kYjRjOTg2NV9WWUN4T0xsMUVrcWplY0xROFV3Q2RrTHFKT3F5WmRkWEhzY2hGOWhLOC1PTTJVMldYLVFIUVphNjBUcUN5T2xvakdIV0lpOGI5M0VkcDZ2aDNaYzBRX2lwQy1ucE1IaVd4SEduczFrUFpR?oc=5","date":"2023-11-22","type":"regulatory","source":"Express Pharma","summary":"Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced neutropenia - Express Pharma","headline":"Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced neutropenia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxQdHc4QUJxMVBZR1dQOGhmbkVoZDF4YkliRkJTa19tcXpEcVJibF9vQW5fUHRQVGRuUjVHQ1BTWXhvZlREOXVpcUdOMlhtSXhEU2FLSnRoOE5fcVhkbU1fZll1TjRXMnZQRkp0c1VsRHlqeVRFUS1LUC04bTMtRHpQTUQ2TU5xd2pxbHQ5ckFiU25GT0pxQXVlV2htRHF4Z21pX0g5UzBJd2IxLXdIMm8zTGJEdmREbDU1b2xnak9pb2Z3cDgwekRhNENULWxpYzAtVTloaTd6VFNrc1BjTHViRU1GbW9HXzBqUW1hcUlFSllfOXNGSjhQWkNYMThHT25RaDFOZXIySWZRSXBmbFdweU51dmw?oc=5","date":"2023-06-07","type":"regulatory","source":"businesswire.com","summary":"ITabMed announces the IND approval from NMPA for A-337, a CD3-activating bispecific antibody targeting EpCAM to treat solid tumors - businesswire.com","headline":"ITabMed announces the IND approval from NMPA for A-337, a CD3-activating bispecific antibody targeting EpCAM to treat so","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2023-03-30","type":"pipeline","source":"Business Standard","summary":"Indian pharma firm Granules opens packaging facility in US' Virginia - Business Standard","headline":"Indian pharma firm Granules opens packaging facility in US' Virginia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPajZYSFMzXzdWejJ3UF9PWjk4RmZXdVVLMk1nSm1YMHltYklvY3V1S1RvdWNEbVVWZVl6UmZVS3VoajA1dEhRYnBkMzVsNjk5ejROd1RfelVuUmM1M3NLemJFODRXM1BKN0NMbTVjOWFuR01WbDhVS1FDNDZ3YmlSV2U4bWtRazJWNlVCYkRRS2Jzb203SXBOOGUwSkdfaTYwMjd2ODRMOXY3MWIxYTdqdE9ZNHNvbUt6SEVQaUpQWlRocE9neVF0VUxTcWtmNWJxODBrQTNsbDMxT1HSAeABQVVfeXFMT2FWajVURXdTZ3NueGNmdDZZTmdlNW41V3VRWjd6V0F6Y3J4U092cmtxUDZHTkJfb012SlJFOWt4WXNqakxyUU5vek53MDRLZ0U1cWFXVEYyYnA0V0RKUkFZWENKSlJGekVUQUVhUEN4cEFUOWk4eGZXY3RNZHd0RWN1MGxhb2R0MzVMSFVfd3k0ZlQ2NDV3Qk1fUWN2NGp2RWNPRXVGYkhMdG80UTV6eDY0bHN2SGx4T3hmVnlaalk1LTdtY1FZeGR1UW42VXRBVEN1UlJ2NklGOWM1azRKRno?oc=5","date":"2022-11-24","type":"pipeline","source":"Medical Dialogues","summary":"Aurobindo Pharma USA arm, Evive Biotech ink pact for commercialisation of Ryzneuta in US - Medical Dialogues","headline":"Aurobindo Pharma USA arm, Evive Biotech ink pact for commercialisation of Ryzneuta in US","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-11-23","type":"pipeline","source":"ET HealthWorld","summary":"Aurobindo unit, Evive Biotech ink licensing pact to commercialise CIN treatment product in US - ET HealthWorld","headline":"Aurobindo unit, Evive Biotech ink licensing pact to commercialise CIN treatment product in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOeHJfUWNQeHhvRk5jSnpHZ0g1X2xOR2MtaE1NQW11TlRxak1zWUpqenlNYklpWXBVV3ZuRVNWRmsyV0NiLUFSTTN4VXBocjNCUHJjNndrTXpQcmw0UEF4dFlTSDhPRHZtblFCZmROcXY1aG10RmxIWVRobFJza2dzdmt2XzlaRzBvWjAxdTlnc1FsbTFTMFBIdFE1T2EtZEdUZi1rc241cW53RjZzdnRsMjdWWGg?oc=5","date":"2021-12-01","type":"pipeline","source":"businesswire.com","summary":"ITabMed Completes Series A-round Financing after Spin-off - businesswire.com","headline":"ITabMed Completes Series A-round Financing after Spin-off","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNZmoxcUxvdjM0ZmZkU3Z4VUpDN0R5Sk1pTF9IV3RZamZFOFZtOEZmME56Q1MtLU5Ga2hmXy11TFJ2OS1VLU9PY2ZYaEFramh0Tks0X1Z4WEFuZ1hPV1ZVUVRYQzRDcnpsWkMwajA4QmgyVFp6OUtxUjN3YmFDeWVWZlJDVC1OT2xSMzhjVzNPa0RMcGI4anNaTzl6MEZPV2d1VGtvbml2N0dBdXJ2TS13M2w0TUh4OVpXZmVV?oc=5","date":"2020-06-24","type":"pipeline","source":"BioSpectrum Asia","summary":"Evive Biotech unveiled as the new corporate brand for Generon Biomed - BioSpectrum Asia","headline":"Evive Biotech unveiled as the new corporate brand for Generon Biomed","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":2,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}